Jean Kim - Profile and Investment Details

Investor Profile

Jean Kim is a Hedge Fund, Venture Capital based in Honolulu, Hawaii, United States with a diverse investment portfolio that includes companies such as RubiconMD, Four Points Innovation, AveXis, CathWorks, CorVent Medical, Neos Therapeutics, Syros PharmaceuticalsCureatr, Intra-Cellular Therapies, Constellation Pharmaceuticals, Recovery Centers of America, Aprecia Pharmaceuticals, Pairwise Plants LLC, Arvinas, iCAD, Ardelyx, SERMO, TriVascular, OMNIlife science, Headspace, Frontier Medicines, Third Wave Technologies, Generation Bio, Nuvation Bio, Editas Medicine, Pacific Biosciences, CytomX Therapeutics, Audentes Therapeutics, Sollis Therapeutics, SentreHEART, Homology Medicines, Adverum Biotechnologies, Oncorus, Proteon Therapeutics, Rhythm Metabolic, Lumos Pharma, Xeris Pharmaceuticals, Conventus Orthopaedics, ESSA Pharma, Akari Therapeutics, Avidity Biosciences, Inc., Practice Fusion, Nivalis Therapeutics, Kiniksa Pharmaceuticals, EndoChoice, GrayBug, Tris Pharma, NeoChord, Advantia Health, Ista Pharmaceuticals, Auspex Pharmaceuticals, Wellfount, Synlogic, Fractyl Laboratories, Epion Health, Blade Therapeutics, Acutus Medical, Eligible, Phoenix, REGENXBIO, MannKind, TESARO, Dracen Pharmaceuticals, Kolltan Pharmaceuticals, LetsGetChecked, SteadyMed Therapeutics, Element Science, Amplo Biotechnology, KemPharm, Contessa, MedAvail, Aralez Pharmaceuticals, Hallux, Sema4, IMRIS Inc., Schrödinger, V-Wave, Shockwave Medical, Assertio, Global Blood Therapeutics, Vital Access, Spark Therapeutics, . Over time, Jean Kim has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Jean Kim is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Patient Care, Health Care, Wellness, Fundraising, Healthcare Innovation, Life Science, Portfolio Management, Medical Technologies, Artificial Intelligence (AI), Information Services, Information Technology (IT), Analytics, Business Development, Finance, Intellectual Property, Biotechnology, Medical Devices, Drug Development, Market Research, Food and Beverage, Clinical Trials, Agriculture, Consulting, Personalized Medicine, Medical Diagnostics, Health Diagnostics, Market Intelligence, Digital Health, Medical, Information Technology, B2B, Therapeutics, Machine Learning, Black / African American Founded, Pharmaceuticals, Healthcare Technology, Risk Management, Public Relations may find it worthwhile to explore potential connections with Jean Kim, as their portfolio suggests a familiarity and interest in this area.

Understanding Jean Kim’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.